EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Medication‐resistant epilepsy is associated with a unique gut microbiota signature

Antonella Riva iD, Eray Sahin, Greta Volpedo, Noemi Teresa Catania, Isabel Venara, Valentina Biagioli, Ganna Balagura iD, Elisabetta Amadori, Carmen De Caro, Emanuele Cerulli Irelli iD, Carlo Di Bonaventura iD, Federico Zara und 3 weitere

Epilepsia · 2025-07 · 66 (7) · 2268-2284

DOI: 10.1111/epi.18367 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Epilepsia, online erschienen am 22.03.2025. Verfasst von Antonella Riva und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genoa, Genoa, Italy. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Drug Resistant Epilepsy. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Fingerprinting a multiomics biomarker profile in patients with STXBP1-RD, MNESYS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Dysfunction of the microbiota–gut–brain axis is emerging as a new pathogenic mechanism in epilepsy, potentially impacting on medication response and disease outcome. We investigated the composition of the gut microbiota in a cohort of medication‐resistant (MR) and medication‐sensitive (MS) pediatric patients with epilepsy.

Methods

Children with epilepsy of genetic and presumed genetic etiologies were evaluated clinically and subgrouped into MR and MS. Age‐matched healthy controls (HCs) were also recruited. A food diary was used to evaluate nutritional habits, and the Rome IV questionnaire was used to record gastrointestinal symptoms. The microbiota composition was assessed in stool samples through 16S rRNA. α‐Diversity (AD) and β‐diversity (BD) were calculated, and differential abundance analysis was performed using linear multivariable models (significance: p .adj < .05).

Results

Forty‐one patients (MR:MS = 20:21) with a mean age of 7.2 years (±4.6 SD) and 27 age‐matched HCs were recruited. No significant differences in AD were found when comparing patients and HCs. Significant positive correlation was found between AD and age (Chao1 p .adj = .0004, Shannon p .adj = .0004, Simpson p .adj = .0028). BD depicted a different bacterial profile in the epilepsy groups compared to HCs (MS vs. HC: Bray–Curtis F = 1.783, p = .001; Jaccard F = 1.24, p = .001; MR vs. HC: Bray–Curtis F = 2.24, p = .001; Jaccard F = 1.364, p = .001). At the genus level, the epilepsy groups were characterized by a significant increase in Hungatella (MS vs. HC: +4.95 log 2 change; MR vs. HC: +6.72 log 2 change); the [Eubacterium] siraeum group changed between the MR and MS subgroups. Significance Epileptic patients display unique gut metagenomic signatures compared to HCs. Moreover, a different ratio of the butyrate‐producing [Eubacterium] siraeum group suggests dissimilarities between patients based on the response to antiseizure medications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeDrug Resistant EpilepsyHumansMaleFemaleChildChild, PreschoolAdolescentAnticonvulsantsFecesRNA, Ribosomal, 16SCohort Studies

Stichwörter der Autor:innen

epilepsygut microbiota signaturemicrobiota–gut–brain axispediatrics

Substanzen

AnticonvulsantsRNA, Ribosomal, 16S

Autor:innen und Institutionen

  • Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genoa, Genoa, Italy.
  • Unit of Medical Genetics, IRCCS Istituto Giannina Gaslini, Genoa, Italy.
  • Biostatistics and Bioinformatics PhD Program, Graduate School of Health Sciences, Acibadem Mehmet Ali Aydinlar University, Acibadem, Turkey.
  • Department of Agricultural, Forest, and Food Sciences, University of Turin, Turin, Italy.
  • IRCCS Istituto Giannina Gaslini, Genoa, Italy.
  • Department of Science of Health, Magna Græcia University of Catanzaro, Catanzaro, Italy.

ORCID-Profile: Antonella Riva, Ganna Balagura, Emanuele Cerulli Irelli, Carlo Di Bonaventura, Emilio Russo, Pasquale Striano

Förderung

  • Fingerprinting a multiomics biomarker profile in patients with STXBP1-RD
  • MNESYS

Zitieren

APA

Riva, A., Sahin, E., Volpedo, G., Catania, N. T., Venara, I., Biagioli, V., Balagura, G., Amadori, E., De Caro, C., Cerulli Irelli, E., Di Bonaventura, C., Zara, F., Sezerman, O. U., Russo, E., & Striano, P. (2025). Medication‐resistant epilepsy is associated with a unique gut microbiota signature. Epilepsia, 66(7), 2268-2284. https://doi.org/10.1111/epi.18367

Vancouver

Riva A, Sahin E, Volpedo G, Catania NT, Venara I, Biagioli V, et al. Medication‐resistant epilepsy is associated with a unique gut microbiota signature. Epilepsia. 2025;66(7):2268-2284. doi:10.1111/epi.18367

BibTeX
@article{Riva2025,
  author = {Riva, Antonella and Sahin, Eray and Volpedo, Greta and Catania, Noemi Teresa and Venara, Isabel and Biagioli, Valentina and Balagura, Ganna and Amadori, Elisabetta and De Caro, Carmen and Cerulli Irelli, Emanuele and Di Bonaventura, Carlo and Zara, Federico and Sezerman, Osman Ugur and Russo, Emilio and Striano, Pasquale},
  title = {Medication‐resistant epilepsy is associated with a unique gut microbiota signature},
  journal = {Epilepsia},
  year = {2025},
  volume = {66},
  number = {7},
  pages = {2268--2284},
  doi = {10.1111/epi.18367}
}
Kostenlos starten →